Skip to main content
Erschienen in: American Journal of Clinical Dermatology 2/2007

01.04.2007 | Correspondence

Etanercept for the Management of Oral Lichen Planus

verfasst von: Noam Yarom

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Excerpt

Oral lichen planus, a cell-mediated immune condition of unknown etiology, affects the oral mucosa in approximately 1–2% of the general population.[1] Although many patients with oral lichen planus are asymptomatic and require no therapy, the management of patients who demonstrate atrophic and erosive lesions is a challenge for the clinician. Treatment modalities include topical, intralesional, or systemic corticosteroids, retinoids, azathioprine, and cyclosporine (ciclosporin). …
Literatur
1.
Zurück zum Zitat Sugerman PB, Savage NW, Walsh LJ. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13 (4): 350–65PubMedCrossRef Sugerman PB, Savage NW, Walsh LJ. The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 2002; 13 (4): 350–65PubMedCrossRef
2.
Zurück zum Zitat Spencer-Green G. Etanercept (Enbrel): update on therapeutic use. Ann Rheum Dis 2000 Nov; 59 Suppl.1: 46–9CrossRef Spencer-Green G. Etanercept (Enbrel): update on therapeutic use. Ann Rheum Dis 2000 Nov; 59 Suppl.1: 46–9CrossRef
3.
Zurück zum Zitat Robinson ND, Guitart J. Recalcitrant, recurrent aphthous stomatitis treated with etanercept. Arch Dermatol 2003 Oct; 139 (10): 1259–62PubMedCrossRef Robinson ND, Guitart J. Recalcitrant, recurrent aphthous stomatitis treated with etanercept. Arch Dermatol 2003 Oct; 139 (10): 1259–62PubMedCrossRef
4.
Zurück zum Zitat Chiang KY, Abhyankar S, Bridges K. Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease. Transplantation 2002 Feb 27; 73 (4): 665–7PubMedCrossRef Chiang KY, Abhyankar S, Bridges K. Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease. Transplantation 2002 Feb 27; 73 (4): 665–7PubMedCrossRef
5.
Zurück zum Zitat Maender JL, Krishnan RS, Angel TA. Complete resolution of generalized lichen planus after treatment with thalidomide. J Drugs Dermatol 2005 Jan-Feb; 4 (1): 86–8PubMed Maender JL, Krishnan RS, Angel TA. Complete resolution of generalized lichen planus after treatment with thalidomide. J Drugs Dermatol 2005 Jan-Feb; 4 (1): 86–8PubMed
Metadaten
Titel
Etanercept for the Management of Oral Lichen Planus
verfasst von
Noam Yarom
Publikationsdatum
01.04.2007
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 2/2007
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200708020-00010

Weitere Artikel der Ausgabe 2/2007

American Journal of Clinical Dermatology 2/2007 Zur Ausgabe

Images in Dermatopathology

Cutaneous Spherulosis (Myospherulosis)

Case Report

Infantile Scurvy

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.